Prolific Machines

Light-controlled cell line development and bioprocessing for biotechs, pharma companies and CDMOs

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

Recent signals

What changed at Prolific Machines in the last 6 months, newest first. Each line links to its public source.

  • 21 Oct 2026 In the news · Prolific Machines announced partnerships with NantWorks and Zylidac Bio CDMO prolific-machines.com

Get signals like these for the companies you sell to →

About Prolific Machines

Prolific Machines develops optogenetics-based cell line development and bioprocessing solutions that use light to control protein expression in cell cultures. Its platform combines optogenetic cell lines, illumination hardware that fits existing bioreactors, and data-driven process optimization.

The company works with biotechs, pharmaceutical companies and CDMOs. It offers preclinical cell line and process development services, platform licensing for in-house manufacturing capability, and CDMO partnerships for GMP supply.

Prolific was founded in 2020 and has open roles in Emeryville, California, mainly in analytical chemistry, cell line development, synthetic biology and hardware engineering. In October 2026 it announced new investments and partnerships with NantWorks and Zylidac Bio CDMO.

Product: Optogenetic cell line development services, light-controllable bioprocess platform with illumination add-on hardware, and platform licensing.

Jobs at Prolific Machines

No open positions listed right now.

More biotech & pharma companies

  • Protara Therapeutics

    Clinical-stage biopharma developing TARA-002 cell therapy and IV choline chloride for cancer and rare disease patients
    United StatesBiotech & pharma
    New on Evolc
  • Ptcbio

    Biopharmaceutical company developing and commercializing medicines for children and adults with serious rare diseases
    United StatesBiotech & pharma4 open jobs
    New on EvolcRemote-friendly
  • Pulmovant

    Developing inhaled therapies for patients with pulmonary diseases, starting with pulmonary hypertension associated
    United StatesBiotech & pharma
    New on Evolc
  • Ratiotx

    Develops targeted radiopharmaceuticals for treating cancer, from discovery through early clinical trials
    United StatesBiotech & pharma
    New on Evolc
  • ReCode Therapeutics

    Develops mRNA and gene-correction medicines for people with genetically defined diseases, including cystic fibrosis
    United StatesBiotech & pharma
    New on Evolc
  • Recursion

    AI-enabled drug discovery and development for pharmaceutical partners and patients with oncology and rare diseases
    United StatesBiotech & pharma1 open job
    Remote-friendlySalary transparent

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content management

  • SanityMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • Next.jsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • ReactMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Recruiting

  • LeverMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.